about
Evaluation of epoetin alpha (rHuEPO) and darbepoetin alpha (DARB) on human burst-colony formation (BFU-E) in culture.Considerations for clinical trial design and data analyses of thorough QT studies using drug-drug interaction.On the cooperativity of biological membranes.Pharmacodynamic interactions between recombinant mouse interleukin-10 and prednisolone using a mouse endotoxemia model.Interactions of prednisolone and other immunosuppressants used in dual treatment of systemic lupus erythematosus in lymphocyte proliferation assays.Down-regulation of heat shock protein 70 improves arsenic trioxide and 17-DMAG effects on constitutive signal transducer and activator of transcription 3 activityStructure-activity relationships of new analogues of arecaidine propargyl ester at muscarinic M1 and M2 receptor subtypes.Synergism between clofarabine and decitabine through p53R2: a pharmacodynamic drug-drug interaction modeling.Synergism between arsenic trioxide and heat shock protein 90 inhibitors on signal transducer and activator of transcription protein 3 activity--pharmacodynamic drug-drug interaction modelingMechanisms of chiral recognition in xenobiotic metabolism and drug-receptor interactions.Assessment of non-linear combination effect terms for drug-drug interactions.Sequential Exposure of Bortezomib and Vorinostat is Synergistic in Multiple Myeloma Cells.Beta-adrenergic blocking agents and anaesthesia: a review.The possible role of conformational isomerism in the biological actions of acetylcholine.Hormone-receptor interactions. Adrenocorticotrophin-(7-24)-octadecapeptide stimulates adipocyte membrane adenylate cyclase without causing lipolysis in fat cells.A comparative study of the action of gamma-aminobutyric acid and piperazine on the lobster muscle fibre and the frog spinal cordThe structure-activity relationships of beta adrenergic drugs and beta adrenergic blocking drugs.Structure-function relationships of peptide fragments of gastrin and cholecystokinin.Coupling toxicokinetics and pharmacodynamics for predicting survival of abalone (Haliotis diversicolor supertexta) exposed to waterborne zinc.Blockade or reversal of the contraction induced by calcium and adrenaline in depolarized arterial smooth muscle.Distinct cellular and therapeutic effects of obatoclax in rituximab-sensitive and -resistant lymphomas.Methixene: a non-competitive antagonist of bradykinin.NK3 receptors mediate an increase in firing rate of midbrain dopamine neurons of the rat and the guinea pig.Acetylcarbocholine and acetylsilicocholine: directly or indirectly acting cholinergic spasmogens?A chemical method for the determination of acetylcholine: its application in a study of presynaptic release and a choline acetyltransferase assay.Prevention by theophylline of beta-2-receptor down regulation in healthy subjects.Stereochemical influences upon antihistamine activity. Further studies of isomeric 4-amino-1,2-diarylbutenes.
P2860
Q33239436-88E35EC0-6C06-44AB-9B5D-71CE6E80CA81Q33574317-AA4716D7-9EDE-4692-99C1-7811E7A2FD63Q33994754-6F78E90D-8CE8-436F-865E-C301A1491E2BQ34335249-79461A1A-1EC6-4F95-B3B4-75E4BCB2F189Q34392717-8820FE02-6192-4AD4-B093-3488F7AA31D3Q35154641-9843060E-A579-4CF1-9F79-2C75D5F78307Q35756230-2EDE6AD5-65F5-464C-A842-02D6FD8D941CQ36275976-04E10192-9D0E-43AE-A3D0-C48DC9C3E7C5Q37275674-1D983049-F64E-423F-A36E-96FA298CF45BQ38790682-9133DD6B-6AD9-4A31-A38B-2E8C4BC597F2Q38957295-E5C991C7-3D4A-49C9-B097-68D531B98D0BQ39013265-FC3B1819-3D71-440B-8B99-4C6011AAFBE0Q39875731-3709C11C-B1CC-4B51-8E0D-A8C648C22075Q39904535-A025C245-7D2C-445A-909A-46FF95E1C479Q40007710-ABE2B744-7AB1-4A9E-A0B4-A1173AE5B4F9Q40019943-0A1C0E51-DD01-4CF8-A790-383746681132Q40053245-61F2292B-D8F5-46BD-BC12-B94494082168Q40103531-EF915697-D4A9-4A9D-A3C5-7D99905CC8B6Q40632625-40013DEC-3F4D-42C2-9CE7-AAB28FEB524BQ41367179-84DB3E18-0B76-42FF-8BD9-408FC6D44B73Q41762088-C86391CD-5464-48C1-95FA-288F52FDB7E3Q43969565-43F6434E-D4EC-4D2D-8000-1EF21AA8153DQ46627333-597D9652-AD3B-4CF6-AF30-FD0B439BCE68Q46927528-9A56E474-A580-441E-A005-D9DAAAC97F21Q49069965-636460CB-ACDC-43E2-B633-112F8FF23CC0Q52415248-4772158E-3F07-4FBF-A4EA-32CCDC9BF476Q52743099-7B28482D-340E-4DD0-B035-4043C3E03C0D
P2860
description
1964 nî lūn-bûn
@nan
1964 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1964 թվականի մարտին հրատարակված գիտական հոդված
@hy
1964年の論文
@ja
1964年論文
@yue
1964年論文
@zh-hant
1964年論文
@zh-hk
1964年論文
@zh-mo
1964年論文
@zh-tw
1964年论文
@wuu
name
A MOLECULAR BASIS FOR DRUG ACTION.
@ast
A MOLECULAR BASIS FOR DRUG ACTION.
@en
type
label
A MOLECULAR BASIS FOR DRUG ACTION.
@ast
A MOLECULAR BASIS FOR DRUG ACTION.
@en
prefLabel
A MOLECULAR BASIS FOR DRUG ACTION.
@ast
A MOLECULAR BASIS FOR DRUG ACTION.
@en
P2860
P1476
A MOLECULAR BASIS FOR DRUG ACTION.
@en
P2093
ARIUENS EJ
SIMONIS AM
P2860
P304
P356
10.1111/J.2042-7158.1964.TB07437.X
P577
1964-03-01T00:00:00Z